MIF and breast cancer: Avalos-Navarro and colleagues, by a study on 150 patients with BC (Luminal A, Luminal B, HER2, Triple-negative), assessed Th17 cytokines profile and the macrophage migration inhibitory factor (MIF) by ELISA assay.